Navigation Links
Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments
Date:1/15/2009

Larger Tip Enables Physicians to Perform Thermage Body Area Treatments Twice as Fast and Improves Patient Treatment Experience

HAYWARD, Calif., Jan. 15 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM) today announced the launch of its new Body Tip 16.0 for the Thermage NXT system for faster, more comfortable body shaping, contouring and cellulite treatments. With five times the surface area coverage of traditional Thermage tips, Body Tip 16.0 cuts body shaping and contouring procedure time in half. In addition, the introduction of an innovative energy delivery system, Comfort Pulse Technology, to the Body Tip 16.0 helps improve overall patient comfort.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/thermage/36633/

"The improved patient comfort associated with the Thermage Body Tip 16.0 provides a significant benefit to my patients, who get the same or better tightening and contouring results with improved comfort," said Robert Weiss, MD, of the Maryland Laser, Skin and Vein Institute. "In addition, the shorter procedure time improves the experience for my staff and the overall value for my practice."

To increase comfort for patients, the Body Tip 16.0 uses Comfort Pulse Technology, a proprietary energy delivery system that gradually reduces the amount of energy delivered in a succession of short, rapid pulses during treatment. By tapering the amount of heat applied in each pulse, patients enjoy more tolerable treatments, while still maintaining the same body tightening and firming results from Thermage treatments.

"The Body Tip 16.0 offers new levels of speed and comfort to my patients who are seeking the benefits of Thermage body shaping treatments including advanced skin tightening and firming," said Michael Kaminer, SkinCare Physicians of Chestnut Hill, MA. "For the first time, I am now able to complete body contouring procedures in under an hour with less discomfort, yet still provide the same positive results that patients expect from Thermage non-invasive aesthetics treatments."

Deep heating and cooling capabilities also ensure that physicians can treat body shaping and cellulite patients with a single tip. These product enhancements enable more treatments to be performed in the same amount of time as well as the type of body areas that can be treated with the Thermage NXT system.

"Thermage is committed to developing breakthrough products that increase physician and patient satisfaction," said Stephen J. Fanning, Chairman of the Board, President and CEO of Thermage. "The Body Tip 16.0 is another example of how we continue to innovate to improve upon the value of Thermage treatments for our physician customers, providing them with tools to enhance their treatment offerings and also increase the viability of their businesses."

The Thermage Body Tip 16.0 is now available worldwide. The tip recently received European CE Mark approval and received clearance from the U.S. Food and Drug Administration in January 2008.

ABOUT SOLTA MEDICAL, INC.

Solta Medical develops innovative products that meet and exceed the needs of the growing aesthetic market. We engineer safe, effective solutions for patients and deliver compelling business opportunities for physicians. To uphold that mission, we are committed to superior innovation, research, development and testing.

Solta Medical is a collaboration of the industry's two leading brands: Thermage, the pioneer in non-invasive skin tightening and contouring, and Fraxel, the premier solution for skin resurfacing. The Thermage and Fraxel systems, both delivering non-invasive treatments with minimal recovery time, enable physicians to offer more compelling solutions to the rapidly growing anti-aging market. For more information about Solta Medical, call 1-877-782-2286 or log on to www.solta.com.

This press release may contain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Thermage's actual results to differ materially from the statements contained herein. Further information on potential risk factors that could affect Thermage's business are detailed in the Company's Form 10-Q for the period ended September 30, 2007. Undue reliance should not be placed on forward-looking statements, which speaks only as of the date they are made. Thermage undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

All our claims are based upon our FDA clearance for the non-invasive treatment of wrinkles and rhytids, including the upper and lower eyelids, and our FDA clearance for the temporary improvement in the appearance of cellulite.

Side effects are generally mild and may include redness, swelling, blisters, bumps and rare instances of surface irregularities.

Solta Medical, Thermage, and NXT, are trademarks of Solta Medical, Inc.


'/>"/>
SOURCE Solta Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: Nutrition Comes to NASCAR
2. Video: Circulatory Care of New Jersey
3. Video: GEN Video Hits Home with Web Audience
4. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
5. Video: Food Expert B. Smith to Provide Healthy Menu Makeovers
6. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
7. Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
8. Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure
9. Video: Holiday Safety Is Important
10. Video: Grin Big With an Award-Winning Smile
11. Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: